Journal List > Prog Med Phys > v.27(4) > 1098562

Chung, Han, Ahn, Kim, and Nonaka: Commissioning and Validation of a Dedicated Scanning Nozzle at Samsung Proton Therapy Center

Abstract

In this study, we present the commissioning and validation results of a dedicated scanning nozzle. The dedicated scanning nozzle is installed in one of the two gantry treatment rooms at Samsung Proton Therapy Center. Following a successful completion of the acceptance test, the commissioning process including the beam data measurement for treatment planning system has been conducted. Extended measurements have been conducted as a validation of the clinical performance of the nozzle and various quality assurance protocols have been prepared.

REFERENCES

1. Wilson R. R.Radiology. 47:487. 1946.
2. Jermann M.Int J Particle Ther. 2:50. 2015.
3. Chung K., Han Y., Kim J., et al. Radiat Oncol J. 33:337. 2015.
4. Chung K., Kim J., Kim D.-H., Ahn S., Han Y.J. Korean Phys Soc. 67:170. 2015.

Fig. 1.
The integrated depth dose curves for the selected beam energies (normalized at peak values).
pmp-27-267f1.tif
Fig. 2.
The clinical range (D90) of the dedicated scanning nozzle at Samsung PTC measured by PTW Bragg peak chamber and MLIC.
pmp-27-267f2.tif
Fig. 3.
The spot size calculated in one sigma for selected beam energies.
pmp-27-267f3.tif
Fig. 4.
Example of mono energetic scan patterns (Left: 150 MeV, Right: 190 MeV) created for validation and daily QA. The gamma passing rates were all above 95% with 3%, 3 mm criteria for both beam energies.
pmp-27-267f4.tif
Fig. 5.
Pseudo 3D dose distribution reconstructed from multi-depth measurement of 2D dose map (With 3% and 3 mm criteria, all XY, XZ, and YZ planes have a passing rate of 100%).
pmp-27-267f5.tif
Table 1.
Selected rehearsal cases for the physical and clinical commissioning of the dedicated scanning nozzle.
Case number Dx. Site 2D Dose QA Note
1 PED 99.0% CSI
2 HCC 97.8%  
3 Brain 98.1%  
4 Lung 98.5%  
5 PED 99.5% Brain
6 Recurrent rectal 98.8%  
7 Head and neck 99.3%  
8 Prostate 99.5% Definitive
9 Esophagus 97.5% Long Y-extent

2D Dose QA: the gamma passing rate of the treatment fieldwith the lowest value.

TOOLS
Similar articles